Podcast Episodes
Back to SearchSeason 2, Episode 20
Season 2
In this week’s episode, we will examine the prognostic significance of co-mutations in IDH-mutated AML, explore an alternative method of warfarin mon…
4 years, 10 months ago
Season 2, Episode 19
Season 2
In this week’s episode, we will review a randomized phase 3 study of patients with high-risk peripheral T-cell lymphoma that compares results from au…
4 years, 10 months ago
Season 2, Episode 18
Season 2
In this week’s episode, we will review a prospective study suggesting that eculizumab discontinuation based on complement genetics is a reasonable an…
4 years, 11 months ago
Season 2, Episode 17
Season 2
In this week’s episode, we will review a study that focuses on the morphologic alterations of stored red blood cells, learn more about how T-cell act…
4 years, 11 months ago
Season 2, Episode 16
Season 2
In this week’s episode, we consider the role of MYC and BCL2 copy number variants in double-hit diffuse large B-cell lymphoma, explore megakaryocyte-…
4 years, 11 months ago
Season 2, Episode 15
Season 2
In this week’s episode, we will review a manuscript that describes a novel inherited bone marrow failure syndrome associated with defective clearance…
4 years, 11 months ago
Season 2, Episode 14
Season 2
In this week’s episode, we discuss recent studies providing new insights on the use of minimal residual disease measurements to guide treatment in pa…
5 years ago
Season 2, Episode 13
Season 2
In this week’s episode, we will learn more about the feasibility of combining IDH inhibitors with intensive chemotherapy in patients with newly diagn…
5 years ago
Season 2, Episode 12
Season 2
In this week’s episode, we look at the role of a previously unidentified variant of DNA methyltransferase 1 as a determinant of beta-thalessemia phen…
5 years ago
Season 2, Episode 11
Season 2
In this week’s episode, will review a study that looks at primary diffuse large B-cell lymphoma of the central nervous system comparing tumor biologi…
5 years ago